Palczuk Linda

Average Profitability
15.45%
Insider Buys Quantity
9
Insider Buys Sum
$324,937.35
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Palczuk Linda

According to the SEC Form 4 filings, Palczuk Linda, being in a position of

  1. director at Avadel Pharmaceuticals plc,
    оver the last 12 months, has bought 3000 shares for $30,568, and sold 0 shares,
    over all time since 2019-12-03, has bought 27500 shares for $162,047, and sold 0 shares.

The largest purchase of all time was on 2018-06-19 and amounted to 6000 shares of Verrica Pharmaceuticals Inc. for $90,000.

Biography of Palczuk Linda

No biography is available at this moment.

2024-12-06PurchaseAvadel Pharmaceuticals plc
AVDL
director
3,000
0.0031%
$10.19$30,568+3.2%
2023-05-09PurchaseAvadel Pharmaceuticals plc
AVDL
director
2,500
0.0038%
$14.76$36,900-6.72%
2022-12-23PurchaseAvadel Pharmaceuticals plc
AVDL
director
2,000
0.0033%
$7.20$14,405+61.03%
2022-05-27PurchaseAvadel Pharmaceuticals plc
AVDL
10,000
0.0108%
$1.60$16,000+179%
2020-08-14PurchaseAvadel Pharmaceuticals plc
AVDL
director
2,500
0.0043%
$7.94$19,850-6.45%
2019-12-03PurchaseAvadel Pharmaceuticals plc
AVDL
director
7,500
0.0201%
$5.91$44,325+28.98%
2019-01-16PurchaseVerrica Pharmaceuticals Inc.
VRCA
Chief Operating Officer
3,000
0.0121%
$10.53$31,590+10.26%
2018-09-17PurchaseVerrica Pharmaceuticals Inc.
VRCA
Chief Operating Officer
2,500
0.0102%
$16.52$41,300-33.62%
2018-06-19PurchaseVerrica Pharmaceuticals Inc.
VRCA
Chief Operating Officer
6,000
0.08%
$15.00$90,000-37.46%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.